Screening for mutations in a genetically heterogeneous disorder: DHPLC versus DNA sequence for mutation detection in multiple genes causing Charcot-Marie-Tooth neuropathy

Purpose: To determine the efficacy of denaturing high-performance liquid chromatography (DHPLC) for mutation detection in genetically heterogeneous diseases using Charcot-Marie-Tooth neuropathy as a model.Methods: (1) Identification of the optimal conditions for mutation scanning by DHPLC using 50 known variants of PMP22, MPZ, GJB1 and EGR2. (2) Comparison of DHPLC with DNA sequencing for mutation detection in 168 patient DNA samples.Results: We established the optimal conditions for screening PMP22, MPZ, GJB1, and EGR2 for mutations. Under optimized conditions, DHPLC was as sensitive as DNA sequencing and detected two mutations that were not identified by automated DNA sequence.Conclusions: DHPLC increases the efficiency and sensitivity of mutation screening in genetically heterogeneous diseases.

[1]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[2]  P. Stankiewicz,et al.  Periaxin mutations cause recessive Dejerine-Sottas neuropathy. , 2001, American journal of human genetics.

[3]  H. Zoghbi,et al.  Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: identification of several novel mutations and polymorphisms. , 2000, American journal of human genetics.

[4]  M. Koenig,et al.  The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy , 2000, Nature Genetics.

[5]  P. Willems.  Genetic causes of hearing loss. , 2000, The New England journal of medicine.

[6]  S. Antonarakis,et al.  Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2000 .

[7]  P. Oefner,et al.  Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. , 1999, Genomics.

[8]  C. Srikumari,et al.  Autosomal recessive retinitis pigmentosa locusRP28 maps between D2S1337 and D2S286 on chromosome 2p11-p15 in an Indian family , 1999, Journal of medical genetics.

[9]  D. Kwiatkowski,et al.  Superiority of Denaturing High Performance Liquid Chromatography over single‐stranded conformation and conformation‐sensitive gel electrophoresis for mutation detection in TSC2 , 1999, Annals of human genetics.

[10]  E. Gross,et al.  A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC , 1999, Human Genetics.

[11]  C. Morton,et al.  Beginning of a molecular era in hearing and deafness , 1999, Clinical genetics.

[12]  M. O’Donovan,et al.  Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. , 1998, Genomics.

[13]  C. Inglehearn,et al.  Molecular genetics of human retinal dystrophies , 1998, Eye.

[14]  S N Thibodeau,et al.  Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. , 1998, Nucleic acids research.

[15]  J. Mendell.  Charcot-Marie-Tooth Neuropathies and Related Disorders , 1998, Seminars in neurology.

[16]  P. Willems,et al.  Nonsyndromic hearing impairment: unparalleled heterogeneity. , 1997, American journal of human genetics.

[17]  D. Rimoin.  Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics , 1997 .

[18]  T. Dryja,et al.  Molecular genetics of retinitis pigmentosa. , 1995, Human molecular genetics.

[19]  M. Katz,et al.  Canine hereditary ceroid-lipofuscinosis: evidence for a defect in the carnitine biosynthetic pathway. , 1995, American journal of medical genetics.

[20]  R. Cotton,et al.  Current methods of mutation detection. , 1993, Mutation research.

[21]  J. Vance,et al.  Hereditary motor and sensory neuropathies. , 1991, Journal of medical genetics.